Skip to Content

Terumo Announces Change of Executive Officers

Feb 06, 2020

TOKYO, JAPAN – February 6, 2020 – Terumo Corporation (TSE: 4543) hereby announces that it has resolved a change of its Executive Officers as follows.

1. Change of Executive Officers (As of April 1, 2020)

Name

New Title

Current Title

Hikaru Samejima

Managing Executive Officer

President, General Hospital Company

Division President, Hospital

Systems Division, General Hospital Company

Managing Executive Officer

President, Cardiac and Vascular Company

Division President, Interventional

Systems Division, Cardiac and Vascular Company

Toshihiko Osada 

Managing Executive Officer

President, Cardiac and Vascular Company

Division President, Interventional

Systems Division, Cardiac and Vascular Company

Senior Executive Officer

General Manager, Strategic
Planning Dept. 

Itaru Sakaguchi 

Senior Executive Officer

 Chief Operations Officer (COO), Interventional Systems Division, Cardiac and Vascular Company

Executive Officer

Chief Operations Officer (COO), Interventional Systems Division, Cardiac and Vascular Company

Hiroshi Nagumo

Executive Officer

President and CEO, Terumo Americas Holding, Inc.

Regional Representative, Latin America 

Executive Officer

Senior Vice President, Blood Center Solutions, Terumo BCT Holding Corp.

President and Representative

Director, Terumo BCT Japan, Inc.

Production Dept. (Terumo BCT)

Fumihisa Hirose 

Executive Officer

General Manager, Strategic Planning Dept.

Executive Officer

Senior Vice President, Cardiac and Vascular Company

Senior Vice President, ME R&D, Cardiac and Vascular Company

Kenichi Ikeda

Executive Officer

General Manager, Sales Promotion (Japan), Hospital Systems Division, General Hospital Company

Branch Manager, Osaka Branch, General Hospital Company

Kazunobu Handa

Executive Officer

General Manager, Corporate Affairs Dept.

General Manager, Corporate Affairs Dept. 

Toshio Nakashima 

Executive Officer

Chief Quality Officer (CQO)

General Manager, Quality Assurance Dept.

Post-Market Surveillance and Vigilance Dept.

General Manager, Quality Assurance Dept. 

Takeshi Kuroo

 Executive Officer

Senior Vice President, Surgical Business, Cardiac and Vascular Company

General Manager, HeartSheet Business Dept., Cardiac and Vascular Company 

Factory Manager, Ashitaka Factory, Cardiac and Vascular Company

Robert DeRyke

Executive Officer

Division President, Cardiovascular Division, Cardiac and Vascular Company

President and CEO, Terumo Cardiovascular Systems Corp. 

Division President, Cardiovascular Division, Cardiac and Vascular Company

President and CEO, Terumo Cardiovascular Systems Corp.

About Terumo

Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for nearly 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide, to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been bolstering healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice. Terumo will further strive to be of value to patients, medical professionals, and society at large.

###

VIEW ALL